What is InFLAMES?
InFLAMES is a research Flagship of the Academy of Finland. The Flagship Director is Academician Sirpa Jalkanen and Vice Directors are Professor Juhani Knuuti and Professor Marko Salmi. The Director has overall responsibility for operations.
Normal immune defence system is vital for health. Overactivity of the immune system leads to the development of autoimmune diseases, such as arthritis, multiple sclerosis and juvenile diabetes. Too weak immune responses, on the other hand, predispose us to cancer and severe bacterial and viral infections.
In the InFLAMES Flagship we aim at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalized therapies.
Our Innovative Ecosystem
The study area of the InFLAMES Flagship is in the heart of both host organizations University of Turku and Åbo Akademi University. It will include joint and coordinated efforts of more than 300 researchers.
Turku has been the foundation and leader of Finnish immunological research for the past 50 years and has also generated major economic activity. The InFLAMES Flagship will transform the immunological research and innovations into economic and societal empowerment in joint efforts with biotech and pharmaceutical companies.
In cooperation with the scientific community and biotech and pharmaceutical companies the overall goals of the InFLAMES Flagship are
- to integrate the immunological and other research activities to develop and exploit new diagnostic and therapeutic tools for personalized medicine
- to introduce new avenues for the collaboration between the universities and industry by boosting public-private companionship
- to enhance entrepreneurship and the translation of new inventions into commercial products
InFLAMES has an Executive Team, which ensures that operations of the Flagship as a whole will be carried out in accordance with InFLAMES’s objectives and strategy.
The members of the Executive Team are:
Representing Officer for the InFLAMES Executive Team
InFLAMES has a Steering Group nominated by the Vice rector of the University of Turku Mika Hannula for a fixed term until 31.12.2024. Steering Group supports and guides the flagship management in its goals and objectives. It will consist of representatives of host institutions (UTU and ÅAU) and partners (the University Hospital, City of Turku) as well as representatives from Industry and the patient organizations. The Steering Group meets 2-3 times a year or when needed.
The members of the Steering Group are:
The Scientific and Impact Advisory Board (SIAB)
InFLAMES Flagship has an appointed Scientific and Impact Advisory Board (SIAB). SIAB supports InFLAMES management in the objectives and scientific goals of the Flagship. It also evaluates research activities, provide insights and comments about flagship’s scientific achievements, impact and aims.
SIAB meets once or twice a year for fixed term until the end of the year 2024.
The members of SIAB are